128 related articles for article (PubMed ID: 38554320)
1. CD146 as a prognostic marker in breast cancer: A meta-analysis.
Sharma A; Somasundaram I; Chabaud MB
J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract][Full Text] [Related]
3. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
4. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer.
Zeng Q; Li W; Lu D; Wu Z; Duan H; Luo Y; Feng J; Yang D; Fu L; Yan X
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1127-32. PubMed ID: 22210108
[TBL] [Abstract][Full Text] [Related]
5. Nestin and cluster of differentiation 146 expression in breast cancer: Predicting early recurrence by targeting metastasis?
Tampaki EC; Tampakis A; Nonni A; Kontzoglou K; Patsouris E; Kouraklis G
Tumour Biol; 2017 Mar; 39(3):1010428317691181. PubMed ID: 28347241
[TBL] [Abstract][Full Text] [Related]
6. ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models.
Li C; Kang L; Fan K; Ferreira CA; Becker KV; Huo N; Liu H; Yang Y; Engle JW; Wang R; Xu X; Jiang D; Cai W
Bioconjug Chem; 2021 Jul; 32(7):1306-1314. PubMed ID: 33475350
[TBL] [Abstract][Full Text] [Related]
7. CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer.
Liu WF; Ji SR; Sun JJ; Zhang Y; Liu ZY; Liang AB; Zeng HZ
Int J Mol Sci; 2012; 13(5):6399-6406. PubMed ID: 22754372
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis.
Zhang Y; Tian J; Qu C; Tang Z; Wang Y; Li K; Yang Y; Liu S
Medicine (Baltimore); 2020 Dec; 99(49):e23359. PubMed ID: 33285715
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD146 as a Potential Target for Preventing Triple Negative Breast Cancer MDA-MB-231 Cell Growth and Dissemination.
Sharma A; Joshkon A; Ladjimi A; Traboulsi W; Bachelier R; Robert S; Foucault-Bertaud A; Leroyer AS; Bardin N; Somasundaram I; Blot-Chabaud M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055160
[No Abstract] [Full Text] [Related]
10. CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma.
Jiang G; Zhang L; Zhu Q; Bai D; Zhang C; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():38. PubMed ID: 26928402
[TBL] [Abstract][Full Text] [Related]
11. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast subtypes define a metastatic matrisome in breast cancer.
Brechbuhl HM; Barrett AS; Kopin E; Hagen JC; Han AL; Gillen AE; Finlay-Schultz J; Cittelly DM; Owens P; Horwitz KB; Sartorius CA; Hansen K; Kabos P
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 32045383
[TBL] [Abstract][Full Text] [Related]
13. CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z; Xu Q; Zhang N; Du X; Xu G; Yan X
Signal Transduct Target Ther; 2020 Aug; 5(1):148. PubMed ID: 32782280
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.
Brechbuhl HM; Finlay-Schultz J; Yamamoto TM; Gillen AE; Cittelly DM; Tan AC; Sams SB; Pillai MM; Elias AD; Robinson WA; Sartorius CA; Kabos P
Clin Cancer Res; 2017 Apr; 23(7):1710-1721. PubMed ID: 27702820
[No Abstract] [Full Text] [Related]
15. Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression.
Dudzik P; Trojan SE; Ostrowska B; Lasota M; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Acta Biochim Pol; 2019 Dec; 66(4):619-625. PubMed ID: 31826047
[TBL] [Abstract][Full Text] [Related]
16. Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases.
Martinez LM; Labovsky V; Calcagno Mde L; Davies KM; Rivello HG; Wernicke A; Calvo JC; Chasseing NA
Pathol Res Pract; 2016 Apr; 212(4):350-5. PubMed ID: 26872535
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Jiang S; Miao XY
Tumour Biol; 2012 Feb; 33(1):173-82. PubMed ID: 22076922
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
19. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
20. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z
Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
